Piedmont Heart Grand Rounds: Thanks to advances in technology and research, infiltrative cardiomyopathies such as cardiac sarcoidosis and amyloidosis are now recognized more frequently by clinicians. Imaging is key to establishing an accurate diagnosis and planning treatment with a multidisciplinary care team. Piedmont Heart cardiologist Steve Sigman, M.D. and heart failure specialist Andrew Darlington, D.O. share best practices and case studies, and discuss patient criteria for cardiac PYP testing.
CME Statement
The following planners and presenters have no relevant financial disclosures: Traci Gordon, Joseph Miller, M.D., Steve Sigman, M.D. Andrew Darlington, D.O., faculty for this enduring material, has the following financial disclosures: Consultant, Pfizer Pharmaceuticals, and Consultant, Akcea Therapeutics.All relevant financial relationships have been mitigated by Piedmont Healthcare.
Piedmont Healthcare is accredited by the Medical Association of Georgia to provide continuing medical education for physicians. Piedmont Healthcare designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
To receive CME credit, please click the button below to complete competency questions and evaluation.
Earn CME Credit
References
- Dorbala S. et al. Consensus Recommendations for multimodality imaging in cardiac amyloidosis. Part 1 of 2. Evidence Base and Standardized Method of Imaging. Journal of Cardiac Failure. Vol 25. No 11. 2019.
- Gillmore J et al. Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis. 133:2404-2412. 2016.
- Ruberg F et al. Transthyretin Cardiac Amyloidosis. 73: No 22. 2019.